Abstract
Community-acquired pneumonia (CAP) is associated with significant morbidity and mortality and is the most common cause of death from infectious diseases. Severe CAP (SCAP) patients that required ICU admission carry the highest mortality rates. Multiple sets of clinical practice guidelines have been published in the past few years addressing the treatment of CAP, and they all agree that CAP patients admitted to the hospital represent a major concern, and appropriate empiric therapy should be instituted to improve clinical outcomes. The purpose of this article is to review the current literature regarding the optimal empiric selection of antibiotic therapy for patients with SCAP. In addition emphasis on the empiric and direct therapy will be made on patients with bacteremic pneumococcal pneumonia.
Keywords: Pneumonia, antibiotics, S. pneumoniae
Current Respiratory Medicine Reviews
Title: Optimal Treatment of Severe Community-Acquired Pneumonia
Volume: 3 Issue: 3
Author(s): Grant W. Waterer and Marcos I. Restrepo
Affiliation:
Keywords: Pneumonia, antibiotics, S. pneumoniae
Abstract: Community-acquired pneumonia (CAP) is associated with significant morbidity and mortality and is the most common cause of death from infectious diseases. Severe CAP (SCAP) patients that required ICU admission carry the highest mortality rates. Multiple sets of clinical practice guidelines have been published in the past few years addressing the treatment of CAP, and they all agree that CAP patients admitted to the hospital represent a major concern, and appropriate empiric therapy should be instituted to improve clinical outcomes. The purpose of this article is to review the current literature regarding the optimal empiric selection of antibiotic therapy for patients with SCAP. In addition emphasis on the empiric and direct therapy will be made on patients with bacteremic pneumococcal pneumonia.
Export Options
About this article
Cite this article as:
Grant W. Waterer and Marcos I. Restrepo , Optimal Treatment of Severe Community-Acquired Pneumonia, Current Respiratory Medicine Reviews 2007; 3 (3) . https://dx.doi.org/10.2174/157339807781387553
DOI https://dx.doi.org/10.2174/157339807781387553 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Inflammatory and Neurodegenerative Pathways in Depression: A New Avenue for Antidepressant Development?
Current Medicinal Chemistry The Role of the Endocannabinoid System in Alzheimers Disease: Facts and Hypotheses
Current Pharmaceutical Design Editorial: Spatial Cognition in Normal Aging, MCI and AD
Current Alzheimer Research Changes in Serum Markers of Inflammation and Endothelial Activation in HIV-Infected Antiretroviral Naive Patients Starting A Treatment with Abacavir-Lamivudine or Tenofovir-Emtricitabine Plus Efavirenz
Current HIV Research Role of Opioid Antagonists in the Treatment of Women with Glucoregulation Abnormalities
Current Pharmaceutical Design Severe Mental Disorders from a Cognitive-Behavioural Perspective: A Comprehensive Review from Conceptualization to Intervention
Current Psychiatry Reviews Flavonoids in the Treatment of Alzheimer’s and Other Neurodegenerative Diseases
Current Medicinal Chemistry Medial Temporal Lobe Volumes in Amnestic Mild Cognitive Impairment and Late-life Depression: Research Synthesis
Current Psychiatry Reviews Neuropeptides in Alzheimer’s Disease: An Update
Current Alzheimer Research Alzheimers Disease: Interactions Between Cholinergic Functions and β- amyloid
Current Alzheimer Research Biochemical Markers in CSF of ALS Patients
Current Medicinal Chemistry Lipid Alterations in the Earliest Clinically Recognizable Stage of Alzheimers Disease: Implication of the Role of Lipids in the Pathogenesis of Alzheimers Disease
Current Alzheimer Research Age-Related Mitochondrial Alterations without Neuronal Loss in the Hippocampus of a Transgenic Model of Alzheimer's Disease
Current Alzheimer Research Treatment Approaches in Elderly Patients with Head and Neck Cancer
Anti-Cancer Agents in Medicinal Chemistry Relevant Modulation by Ferrous Ions of N-Methyl-D-Aspartate Receptors in Ischemic Brain Injuries
Current Neurovascular Research Combination of P300 and CSF β-Amyloid(1-42) Assays May Provide a Potential Tool in the Early Diagnosis of Alzheimers Disease
Current Alzheimer Research Vitamin D Levels in Middle-Aged Patients with Obstructive Sleep Apnoea Syndrome
Current Vascular Pharmacology Review of Synthesis, Biological Assay and QSAR Studies of β-Secretase Inhibitors
Current Computer-Aided Drug Design Use of the Bradykinin Agonist, Cereport as a Pharmacological Means of Increasing Drug Delivery to the CNS
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Spatio-Temporal Fluctuations of Neural Dynamics in Mild Cognitive Impairment and Alzheimer’s Disease
Current Alzheimer Research